Cancer drug ruling 'will help poor people'

India’s Supreme Court today rejected drug maker Novartis’ right to patent a new version of a life-saving cancer drug, a lawyer for health care activists said.

The landmark ruling is a victory for India’s €20bn generic drug industry that provides cheap medicines to millions around the world.